[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Vistra Corp. (VST) Form 144 notice: An authorized person filed to sell 21,362 common shares with an aggregate market value of $4,481,773.62, representing a small fraction of the 338,820,324 shares outstanding. The sale is scheduled for 09/15/2025 through Fidelity Brokerage Services on the NYSE. The securities were acquired through stock options granted in 2016 and 2018 and payment is indicated as cash. Recent insider sales show 84,040 shares sold on 09/10–09/12/2025 for gross proceeds of $17,260,865.24. The filer attests no undisclosed material adverse information.

Positive

• Regulatory compliance: Form 144 filed, providing required disclosure of proposed insider sales
• Immaterial market impact: 21,362 shares (~0.0063% of outstanding) is a negligible portion of 338,820,324 shares outstanding

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider filing shows routine option-derived sales; size is immaterial versus outstanding shares.

The Form 144 reports a proposed sale of 21,362 common shares valued at $4.48 million to occur on 09/15/2025 via Fidelity on the NYSE. The shares were acquired under option grants from 2016 and 2018 and will be sold for cash. Recent sales by the same person totaled 84,040 shares for $17.26 million across 09/10–09/12/2025. Relative to 338.82 million shares outstanding, these transactions represent a de minimis ownership dilution and appear consistent with option exercise and liquidity events rather than a company-specific signal.

Corporate Governance Expert

TL;DR: Filing demonstrates compliance with disclosure rules; no evidence of undisclosed material issues.

The notice includes the standard attestation that the seller is unaware of any undisclosed material adverse information and documents the origin of the shares (options granted in 2016 and 2018). The filing provides broker details, exact share counts, acquisition dates, and recent sale history, supporting regulatory transparency. There is no indication in the document of a Rule 10b5-1 plan adoption date or other unusual arrangements disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21362	4481773.62	338820324	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Options Granted - 10/11/2016	Issuer			19200	09/15/2025	Cash
Common	09/15/2025	Options Granted - 04/09/2018	Issuer			2162	09/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Vistra's (VST) Form 144 report?

It reports a proposed sale of 21,362 common shares valued at $4,481,773.62 to be sold on 09/15/2025 through Fidelity on the NYSE.

Were the shares acquired or from option grants for VST?

Yes. The shares were acquired via options granted on 10/11/2016 (19,200 shares) and 04/09/2018 (2,162 shares).

Has the filer recently sold other Vistra shares?

Yes. The filer sold a total of 84,040 shares on 09/10–09/12/2025 for gross proceeds of $17,260,865.24.

Does the filing disclose any undisclosed material information about Vistra?

The signer represents they do not know of any material adverse information that has not been publicly disclosed.

Which broker and exchange are used for the proposed sale?

The sale is to be executed through Fidelity Brokerage Services LLC and listed on the NYSE.